Dermatologicals in the Netherlands
DERMATOLOGICALS IN THE NETHERLANDS
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Weak Growth Prospects for Dermatologicals
the Continued Preference for Prescription Products
Vaginal Antifungals Is One of Few Growth Areas
Competitive Landscape
Remark Pharma Maintains Its Lead
Canesten Gyno Performs Strongly
Private Label Is Expected To Remain Marginal
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023
Executive Summary
Moderate Value Growth, Largely Driven by Non-otc Categories
OTC Sales Are Not (yet) Lifted by the Brighter Macroeconomy
Pharmaceutical Multinationals Dominate, With Private Label the Main Rival
Supermarkets Gains Ground, To the Detriment of Chemists/pharmacies
Modest Value Growth Over the Forecast Period
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Sources
Summary 2 Research Sources
Dermatologicals recorded only moderate growth in 2018, performing below average compared with OTC products overall. In contrast to other OTC categories, the further improvement in the macroeconomic environment, including rising disposable incomes, did not provide a noticeable stimulus to dermatologicals. One reason is that many consumers still prefer prescription products to treat skin conditions; this leaves little room for growth in non-prescription dermatologicals.
Euromonitor International's Dermatologicals in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.